Journal Oncology Times
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Study Explores Durvalumab Plus Ceralasertib in Immunotherapy-Resistant Lung Cancer
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0524Published: May 2024Expires: 6/5/2026Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Media: -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Behavioral Economics Can Help Cancer Patients Quit Smoking
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0324Published: March 2024Expires: 3/6/2026Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Media: -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Study Highlights Impact of Housing Assistance Programs on Cancer Screening
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0224Published: February 2024Expires: 3/6/2026Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Media: -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Treatment for Metastatic Colorectal Cancer With Mutated KRAS G12C
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0124Published: January 2024Expires: 3/6/2026Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Media: -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Mortality Risk of Second Malignancies in Childhood Cancer Survivors
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1223Published: December 2023Expires: 12/5/2025Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Media: -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Treatment Regimen Holds Promise for Patients With Advanced Bladder Cancer
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1123Published: November 2023Expires: 9/5/2025Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Topics: Bladder Cancer -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Study Finds Link Between Lorazepam & Worse Outcomes in Pancreatic Cancer
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1023Published: October 2023Expires: 9/5/2025Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Specialties: Advanced Practice Nursing, Oncology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Pirtobrutinib Shows Promise for Chronic Lymphocytic Leukemia
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0923Published: September 2023Expires: 9/5/2025Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Specialties: Advanced Practice Nursing, Oncology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Potential of Fixed-Duration Ibrutinib + Venetoclax in High-Risk Cll
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0823Published: August 2023Expires: 6/5/2025Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Specialties: Advanced Practice Nursing, OncologyTopics: Cancer , Chronic Lymphocytic Leukemia (CLL) -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Dabrafenib Plus Trametinib Shows Promise in BRAFV600E-Mutated Rare Cancers
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0723Published: July 2023Expires: 6/5/2026Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Specialties: Advanced Practice Nursing, OncologyTopics: Cancer , Chemotherapy